A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus

NCT05086445 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3502970
DRUG: Placebo

Sponsor

Eli Lilly and Company